BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25833766)

  • 21. Genetic and environmental findings in early-onset Parkinson's disease Brazilian patients.
    Aguiar Pde C; Lessa PS; Godeiro C; Barsottini O; FelĂ­cio AC; Borges V; Silva SM; Saba RA; Ferraz HB; Moreira-Filho CA; Andrade LA
    Mov Disord; 2008 Jul; 23(9):1228-33. PubMed ID: 18464276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation analysis of PARK2 in a Uyghur family with early-onset Parkinson's disease in Xinjiang, China.
    Li H; Yusufujiang A; Naser S; Zhu Y; Maimaiti M; He X; Bu J; Meng X; Wang M; Li J; Dina B; Yang L; Nayi Z; Dang H; Wang C; Amiti D; Aji A; Yusufu N; Jiao Y; Duan F
    J Neurol Sci; 2014 Jul; 342(1-2):21-4. PubMed ID: 24831986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replication-Based Rearrangements Are a Common Mechanism for SNCA Duplication in Parkinson's Disease.
    Seo SH; Bacolla A; Yoo D; Koo YJ; Cho SI; Kim MJ; Seong MW; Kim HJ; Kim JM; Tainer JA; Park SS; Kim JY; Jeon B
    Mov Disord; 2020 May; 35(5):868-876. PubMed ID: 32039503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-resolution survey in familial Parkinson disease genes reveals multiple independent copy number variation events in PARK2.
    Wang L; Nuytemans K; Bademci G; Jauregui C; Martin ER; Scott WK; Vance JM; Zuchner S
    Hum Mutat; 2013 Aug; 34(8):1071-4. PubMed ID: 23616242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions.
    Eryilmaz IE; Cecener G; Erer S; Egeli U; Tunca B; Zarifoglu M; Elibol B; Bora Tokcaer A; Saka E; Demirkiran M; Akbostanci C; Dogu O; Colakoglu B; Kenangil G; Kaleagasi H
    Neurol Res; 2017 Nov; 39(11):965-972. PubMed ID: 28830306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PARK2 gene mutations in early onset Parkinson's disease patients of South India.
    Padmaja MV; Jayaraman M; Srinivasan AV; Srisailapathy CR; Ramesh A
    Neurosci Lett; 2012 Aug; 523(2):145-7. PubMed ID: 22766139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct patterns of complex rearrangements and a mutational signature of microhomeology are frequently observed in PLP1 copy number gain structural variants.
    Bahrambeigi V; Song X; Sperle K; Beck CR; Hijazi H; Grochowski CM; Gu S; Seeman P; Woodward KJ; Carvalho CMB; Hobson GM; Lupski JR
    Genome Med; 2019 Dec; 11(1):80. PubMed ID: 31818324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rare pathogenic microdeletions and tandem duplications are microhomology-mediated and stimulated by local genomic architecture.
    Vissers LE; Bhatt SS; Janssen IM; Xia Z; Lalani SR; Pfundt R; Derwinska K; de Vries BB; Gilissen C; Hoischen A; Nesteruk M; Wisniowiecka-Kowalnik B; Smyk M; Brunner HG; Cheung SW; van Kessel AG; Veltman JA; Stankiewicz P
    Hum Mol Genet; 2009 Oct; 18(19):3579-93. PubMed ID: 19578123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.
    Kay DM; Stevens CF; Hamza TH; Montimurro JS; Zabetian CP; Factor SA; Samii A; Griffith A; Roberts JW; Molho ES; Higgins DS; Gancher S; Moses L; Zareparsi S; Poorkaj P; Bird T; Nutt J; Schellenberg GD; Payami H
    Neurology; 2010 Sep; 75(13):1189-94. PubMed ID: 20876472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alu-mediated diverse and complex pathogenic copy-number variants within human chromosome 17 at p13.3.
    Gu S; Yuan B; Campbell IM; Beck CR; Carvalho CM; Nagamani SC; Erez A; Patel A; Bacino CA; Shaw CA; Stankiewicz P; Cheung SW; Bi W; Lupski JR
    Hum Mol Genet; 2015 Jul; 24(14):4061-77. PubMed ID: 25908615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FoSTeS, MMBIR and NAHR at the human proximal Xp region and the mechanisms of human Xq isochromosome formation.
    Koumbaris G; Hatzisevastou-Loukidou H; Alexandrou A; Ioannides M; Christodoulou C; Fitzgerald T; Rajan D; Clayton S; Kitsiou-Tzeli S; Vermeesch JR; Skordis N; Antoniou P; Kurg A; Georgiou I; Carter NP; Patsalis PC
    Hum Mol Genet; 2011 May; 20(10):1925-36. PubMed ID: 21349920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic study of a Parkinson's disease pedigree caused by compound heterozygous mutations in PARK2 gene].
    Chen M; Cen Z; Chen Y; Zheng X; Xie F; Chen S; Luo W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Dec; 35(6):815-818. PubMed ID: 30512153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterisation of a novel aberrant pattern of intron 1 inversion with concomitant large insertion and deletion within the F8 gene.
    You G; Chi K; Lu Y; Ding Q; Dai J; Xi X; Wang H; Wang X
    Thromb Haemost; 2014 Aug; 112(2):264-70. PubMed ID: 24696066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of exon dosage using MLPA in South African Parkinson's disease patients.
    Keyser RJ; Lombard D; Veikondis R; Carr J; Bardien S
    Neurogenetics; 2010 Jul; 11(3):305-12. PubMed ID: 20013014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
    Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
    Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining the ends of Parkin exon 4 deletions in two different families with Parkinson's disease.
    Clarimon J; Johnson J; Dogu O; Horta W; Khan N; Lees AJ; Hardy J; Singleton A
    Am J Med Genet B Neuropsychiatr Genet; 2005 Feb; 133B(1):120-3. PubMed ID: 15635662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct X chromosomal rearrangements in four haemophilia B patients with entire F9 deletion.
    Nakamura Y; Ando Y; Takagi Y; Murata M; Kozuka T; Nakata Y; Hasebe R; Takagi A; Matsushita T; Shima M; Kojima T
    Haemophilia; 2016 May; 22(3):433-9. PubMed ID: 26686734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complex genomic rearrangements in the dystrophin gene due to replication-based mechanisms.
    Baskin B; Stavropoulos DJ; Rebeiro PA; Orr J; Li M; Steele L; Marshall CR; Lemire EG; Boycott KM; Gibson W; Ray PN
    Mol Genet Genomic Med; 2014 Nov; 2(6):539-47. PubMed ID: 25614876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inheritance of Charcot-Marie-Tooth disease 1A with rare nonrecurrent genomic rearrangement.
    Choi BO; Kim NK; Park SW; Hyun YS; Jeon HJ; Hwang JH; Chung KW
    Neurogenetics; 2011 Feb; 12(1):51-8. PubMed ID: 21193943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.